Expert Panel Discussion: Combining Kinase Inhibitor Therapies for Supercharged Targeting

Time: 12:30 pm
day: Day Two


  • Discussing multiple points of entry of oncogenic pathways to enhance targeting and therapeutic impact
  • Redefining outcomes with combination therapies across indications, from oncology, dermatology, respiratory & autoimmune diseases
  • Assessing the safety issues with polypharmacy of 1 or more kinases and mitigating off-target effects